Focus on lung cancer

Cancer Cell

Volumn 1, Issue 1, 2002, Pages 49-52

  Minna, John D ^a   Roth, Jack A ^b   Gazdar, Adi F ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANGIOGENESIS INHIBITOR; CANCER VACCINE; CARBOPLATIN; CISPLATIN; CYCLIN DEPENDENT KINASE INHIBITOR; DOCETAXEL; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; ETOPOSIDE; FLUORODEOXYGLUCOSE F 18; GEMCITABINE; HER DIMERIZATION INHIBITOR; IRINOTECAN; MATRIX METALLOPROTEINASE INHIBITOR; NAVELBINE; PACLITAXEL; PROTEIN FARNESYLTRANSFERASE INHIBITOR; PROTEIN TYROSINE KINASE INHIBITOR; SELENIUM; TOPOTECAN;

CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PREVENTION; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; EARLY DIAGNOSIS; GENE MUTATION; GENE REPLACEMENT THERAPY; GENETIC EPIDEMIOLOGY; GENETIC POLYMORPHISM; HISTOLOGY; HUMAN; INCIDENCE; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; METASTASIS; NICOTINE REPLACEMENT THERAPY; PATHOGENESIS; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SMOKING; STATISTICS; GENETICS; HEALTH; LUNG TUMOR; RISK FACTOR;

HUMANS; INCIDENCE; LUNG NEOPLASMS; RISK FACTORS; WORLD HEALTH;

EID: 0036463481     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1535-6108(02)00027-2     Document Type: Review

References (26)

1. Amos, C.I., Xu, W., and Spitz, M.R. (1999). Is there a genetic basis for lung cancer susceptibility? Cancer Res. 151, 3-12.
2. Belinsky, S.A., Nikula, K.J., Palmisano, W.A., Michels, R., Saccomanno, G., Gabrielson, E., Baylin, S.B., and Herman, J.G. (1998). Proc. Natl. Acad. Sci. USA, 95, 11891-11896.
3. Bunn, P.A., Jr. (2001). Triplet combination chemotherapy and targeted therapy regimens. Oncology (Huntingt.) 15, 26-32.
4. Burbee, D., Forgacs, E., Zöchbauer-Müller, S., Shivakuma, L., Fong, K., Gao, B., Randle, D., Virmani, A., Bader, S., Sekido, Y., et al. (2001). RASSF1A in the 3p21.3 homozygous deletion region:epigenetic inactivation in lung and breast cancer and suppression of the malignant phenotype. J. Natl. Cancer Inst. 93, 691-699.
5. Dammann, R., Li, C., Yoon, J.H., Chin, PL., Bates, S., and Pfeifer, G.P (2000). Nat. Genet. 25, 315-319.
6. Fiore, M.C., Jorenby, D.E., and Baker, T.B. (1997). Smoking cessation : principles and practice based upon the AHCPR Guideline, 1996. Agency for Health Care Policy and Research. Ann. Behav. Med. 19, 213-219.
7. Fong, K.M., Sekido, Y., and Minna, J.D. (2001). The molecular basis of lung carcinogenesis. In The Molecular Basis of Human Cancer, W.B. Coleman and G. Tsongalis, eds. (Totowa, NJ: Humana Press), pp. 379-405.
8. Gibbs, J.B. (2000). Mechanism-based target identification and drug discovery in cancer research. Science 287, 1969-1973.
9. Girard, L., Zochbauer-Muller, S., Virmani, A.K., Gazdar, A.F., and Minna, J.D. (2000). Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering. Cancer Res. 60, 4894-4906.
10. Hecht, S.S. (1999). Tobacco smoke carcinogens and lung cancer. J. Natl Cancer Inst. 91, 1194-1210.
11. Henschke, C.I., McCauley, D.I., Yankelevitz, D.F., Naidich, D.P., McGuinness, G., Miettinen, O.S., Libby, D.M., Pasmantier, M.W., Koizumi, J., Altorki, N.K., and Smith, J.P. (1999). Early lung cancer action project: overall design and findings from baseline screening. Lancet 354, 99-105.
12. Hirsch, F.R., Franklin, W.A., Gazdar, A.F., and Bunn, P.A., Jr. (2001). Early detection of lung cancer: clinical perspectives of recent advances in biology and radiology. Clin. Cancer Res. 7, 5-22.
13. Lam, S., Kennedy, T., Unger, M., Miller, Y.E., Gelmont, D., Rusch, V., Gipe, B., Howard, D., LeRiche, J.C., Coldman, A., and Gazdar, A.F. (1998). Localization of bronchial intraepithelial neoplastic lesions by fluorescence bronchoscopy. Chest 113, 696-702.
14. Lippman, S.M., and Spitz, M.R. (2001). Lung cancer chemoprevention: an integrated approach. J. Clin. Oncol. 79, 74S-82S.
15. Minna, J. (2000). Neoplasms of the lung. In Harrison's Principles of Internal Medicine, 15th edition, A.S. Fauci, E. Braunwald, K.J. Isselbacher, J.D. Wilson, J.B. Martin, D.L. Kasper, S.L. Hauser, and D.L. Longo, eds. (New York: McGraw-Hill), chapter 88.
16. Park, I.W., Wistuba, I.I., Maitra, A., Milchgrub, S., Virmani, A.K., Minna, J.D., and Gazdar, A.F. (1999). Multiple clonal abnormalities in the bronchial epithelium of patients with lung cancer. J. Natl. Cancer Inst. 97, 1863-1868.
17. Parkin, D.M., Bray, F.I., and Devesa, S.S. (2001). Cancer burden in the year 2000. The global picture. Eur. J. Cancer 37 (Suppl 8), 4-66.
18. Peto, R., Chen, Z.M., and Boreham, J. (1999). Tobacco - the growing epidemic. Nat. Med. 5, 15-17.
19. Peto, R., Darby, S., Deo, H., Silcocks, P., Whitley, E., and Doll, R. (2000). Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. BMJ 327, 323-329.
20. Pieterman, R.M., van Putten, J.W., Meuzelaar, J.J., Mooyaart, E.L., Vaalburg, W., Koeter, G.H., Fidler, V., Pruim, J., and Groen, H.J. (2000). Preoperative staging of non-small-cell lung cancer with positron-emission tomography. N. Engl. J. Med. 343, 254-261.
21. Tomizawa, Y., Sekido, Y., Kondo, M., Gao, B., Yokota, J., Roche, J., Drabkin, H., Lerman, M.I., Gazdar, A.F., and Minna, J.D. (2001). Inhibition of lung cancer cell growth and induction of apoptosis after reexpression of 3p21.3 candidate tumor suppressor gene SEMA3B. Proc. Natl. Acad. Sci. USA 98, 13954-13959.
22. Wistuba, I.I., Lam, S., Behrens, C., Virmani, A.K., Fong, K.M., LeRiche, J., Samet, J.M., Srivastava, S., Minna, J.D., and Gazdar, A.F. (1997). Molecular damage in the bronchial epithelium of current and former smokers. J. Natl. Cancer Inst. 89, 1366-1373.
23. Wistuba, I.I., Behrens, C., Milchgrub, S., Bryant, D., Hung, J., Minna, J.D., and Gazdar, A.F. (1999). Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma. Oncogene 18, 643-650.
24. Wistuba, I., Behrens, C., Virmani, A.K., Mele, G., Milchgrub, S., Girard, L., Rondon, J.W., 3rd, Garner, H.R., McKay, B., Latif, F., et al. (2000). High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints. Cancer Res. 60, 1949-1960.
25. Zochbauer-Muller, S., Fong, K.M., Virmani, A.K., Geradts, J., Gazdar, A.F., and Minna, J.D. (2001). Aberrant promoter methylation of multiple genes in non-small cell lung cancers. Cancer Res. 61, 249-255.
26. Zochbauer-Muller, S., Gazdar, A.F., and Minna, J.D. (2002). Molecular pathogenesis of lung cancer. Annu. Rev. Physiol. 64, 681-708.